123 results on '"Ulusakarya, Ayhan"'
Search Results
2. Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients
3. Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.
4. Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer
5. A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
6. Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
7. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
8. Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
9. Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer
10. A multicenter telemonitoring-telecare study with automatic assessment of physiological parameters and patient-reported outcomes in remote pancreatic cancer patients on mFOLFIRINOX: Interim technology report.
11. Is cure possible for breast cancer metastatic to the liver?
12. Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer : results from the International EORTC 05011 Trial
13. Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
14. Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial
15. Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
16. Improving FOLFIRINOX safety in pancreatic cancer patients through multidimensional remote monitoring and proactive care using a domomedecine mobile platform.
17. Hepatic metastases resection after cetuximab: are we missing something?
18. Acute renal failure related to oxaliplatin-induced intravascular hemolysis
19. Novel somatic mutations of the VHL gene in an erythropoietin-producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells
20. Symptoms in Cancer Patients and an Unusual Tumor: CASE 1. Regression of Hypertrophic Pulmonary Osteoarthropathy Following Chemotherapy for Lung Metastases of a Nasopharyngeal Carcinoma
21. A survey of women with breast or gynecological cancer: Parcours de femmes 2001
22. Aspergilloma
23. The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project)
24. PRODIGE 53-UCGI 30 (SULTAN): A randomized phase II study comparing treatment intensification with hepatic arterial infusion chemotherapy plus systemic chemotherapy to systemic chemotherapy alone in patients with liver-only colorectal metastases considered still non resectable after at least two months of systemic induction chemotherapy.
25. Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or secondline treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial.
26. Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home—Results From a Pilot Study
27. Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer
28. Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study
29. Patient-tailored FOLFIRINOX in the first-line treatment of patients (pts) with advanced pancreatic cancer (PC).
30. Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study (Preprint)
31. Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project
32. Objective sleep duration (SD) and overall survival (OS) in patients (pts) with metastatic colorectal cancer (MCC).
33. Symptoms associated with circadian rest-activity rhythm disruption in 237 patients with metastatic colorectal cancer.
34. Subjective sleep problems and objective circadian disruption: Impact on outcomes in patients with metastatic colorectal cancer (MCC).
35. Detection of circulating tumor cells (CTCs) in central venous blood (CVB) versus peripheral venous blood (PVB) in patients with metastatic cancers.
36. Efficacy and safety of chronomodulated hepatic arterial infusion (chronoHAI) of irinotecan (I), oxaliplatin (0) and fluorouracil (F) as salvage treatment for patients (pts) with heavily pretreated liver-predominant metastatic colorectal cancer (MCC).
37. Very late recurrence of Diethylstilbestrol - related clear cell carcinoma of the cervix: case report
38. The circadian timing system in clinical oncology
39. Efficacy and Safety of Triweekly Docetaxel, Oxaliplatin, Fluorouracil, and Folinic Acid (DOFF) in Patients with Advanced Gastric or Gastroesophageal Adenocarcinoma
40. Patient-reported sleep disruption as an independent prognostic factor for overall survival in metastatic colorectal cancer.
41. Sleep Disruption in Breast Cancer Patients and Survivors
42. Post-transplant lymphoproliferative disorder (PTLD) after liver transplantation: Report of 16 cases from a single center.
43. Acute renal failure related to oxaliplatin-induced intravascular hemolysis
44. Modulation of FU With High-Dose Folinic Acid Is Effective for Treatment of Patients With Gastric Carcinoma
45. Novel somatic mutations of the VHL gene in an erythropoietin‐producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells
46. Blepharitis Induced by Epidermal Growth Factor Receptor-Targeting Therapy
47. Extraskeletal Osteosarcoma of the Mediastinum After Treatment of a Mediastinal Germ-Cell Tumor
48. Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia
49. Plasma Cell Meningitis after an Autograft in a Patient with Multiple Myeloma
50. Gallium Scan in the Evaluation of Post Chemotherapy Mediastinal Residual Masses of Aggressive Non-Hodgkin's Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.